review article | Q7318358 |
scholarly article | Q13442814 |
P2093 | author name string | Henry Lin | |
Sudha Singh | |||
P2860 | cites work | Genomic analysis identifies association of Fusobacterium with colorectal carcinoma | Q24603176 |
Desulfovibrio desulfuricans bacteremia and review of human Desulfovibrio infections | Q24672454 | ||
Influence of dietary factors on the clinical course of ulcerative colitis: a prospective cohort study | Q24685821 | ||
Hydrogen sulfide-based therapeutics and gastrointestinal diseases: translating physiology to treatments | Q26998572 | ||
Carbon monoxide, hydrogen sulfide, and nitric oxide as signaling molecules in the gastrointestinal tract | Q27026586 | ||
Microbial ecology: human gut microbes associated with obesity | Q27861004 | ||
Gaseous mediators nitric oxide and hydrogen sulfide in the mechanism of gastrointestinal integrity, protection and ulcer healing | Q28083755 | ||
Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases | Q28131810 | ||
Inhibition of hydrogen sulfide generation contributes to gastric injury caused by anti-inflammatory nonsteroidal drugs | Q28192729 | ||
Hydrogen sulfide is an endogenous modulator of leukocyte-mediated inflammation | Q28200154 | ||
Purification and characterization of rat liver microsomal thiol methyltransferase | Q28263409 | ||
H2S signals through protein S-sulfhydration | Q28511531 | ||
3-Mercaptopyruvate sulfurtransferase produces hydrogen sulfide and bound sulfane sulfur in the brain | Q28513550 | ||
Tissue and subcellular distribution of mercaptopyruvate sulfurtransferase in the rat: confocal laser fluorescence and immunoelectron microscopic studies combined with biochemical analysis | Q28569061 | ||
A metagenome-wide association study of gut microbiota in type 2 diabetes | Q29547726 | ||
Gut inflammation provides a respiratory electron acceptor for Salmonella | Q29615318 | ||
Effect of oral consumption of probiotic Lactobacillus planatarum P-8 on fecal microbiota, SIgA, SCFAs, and TBAs of adults of different ages | Q31169716 | ||
Hydrogen sulfide ameliorates ischemia/reperfusion-induced hepatitis by inhibiting apoptosis and autophagy pathways | Q33747476 | ||
Detoxification of hydrogen sulfide and methanethiol in the cecal mucosa | Q33859570 | ||
The effect of hydrogen sulfide donors on lipopolysaccharide-induced formation of inflammatory mediators in macrophages | Q33875055 | ||
Binding of hydrogen sulfide by bismuth does not prevent dextran sulfate-induced colitis in rats | Q33915400 | ||
Arsenic thiolation and the role of sulfate-reducing bacteria from the human intestinal tract | Q34007617 | ||
Sequence of cDNA for rat cystathionine gamma-lyase and comparison of deduced amino acid sequence with related Escherichia coli enzymes | Q34052124 | ||
Oral administration of recombinant Lactococcus lactis expressing HSP65 and tandemly repeated P277 reduces the incidence of type I diabetes in non-obese diabetic mice | Q34089896 | ||
Impaired hydrogen sulfide synthesis and IL-10 signaling underlie hyperhomocysteinemia-associated exacerbation of colitis | Q34218443 | ||
The effect of antibiotics and bismuth on fecal hydrogen sulfide and sulfate-reducing bacteria in the rat | Q34276031 | ||
Small intestinal bacterial overgrowth: a framework for understanding irritable bowel syndrome | Q34341766 | ||
H(2)S-releasing aspirin protects against aspirin-induced gastric injury via reducing oxidative stress | Q34431045 | ||
Fecal hydrogen sulfide production in ulcerative colitis | Q34454318 | ||
Colonic luminal hydrogen sulfide is not elevated in ulcerative colitis | Q34460913 | ||
A gut microbiota-targeted dietary intervention for amelioration of chronic inflammation underlying metabolic syndrome | Q34629179 | ||
Annexin A1 mediates hydrogen sulfide properties in the control of inflammation | Q34634640 | ||
Enhanced synthesis and diminished degradation of hydrogen sulfide in experimental colitis: a site-specific, pro-resolution mechanism | Q34938166 | ||
Vascular endothelium expresses 3-mercaptopyruvate sulfurtransferase and produces hydrogen sulfide. | Q34992435 | ||
Hydrogen sulfide preconditioning protects rat liver against ischemia/reperfusion injury by activating Akt-GSK-3β signaling and inhibiting mitochondrial permeability transition | Q34994670 | ||
Hydrogen sulfide causes vanilloid receptor 1-mediated neurogenic inflammation in the airways | Q35049073 | ||
Alteration of the intestinal microbiota as a cause of and a potential therapeutic option in irritable bowel syndrome. | Q35105259 | ||
The L-cysteine desulfhydrase of Escherichia coli | Q40757780 | ||
Administration of hydrogen sulfide protects ischemia reperfusion-induced acute kidney injury by reducing the oxidative stress. | Q40770083 | ||
Inhibition of lipid peroxidation by superoxide dismutase following regional intestinal ischemia and reperfusion | Q41456271 | ||
A Case of Liver Abscess with Desulfovibrio desulfuricans Bacteremia | Q41515495 | ||
GYY4137, a hydrogen sulfide‑releasing molecule, inhibits the inflammatory response by suppressing the activation of nuclear factor‑kappa B and mitogen‑activated protein kinases in Coxsackie virus B3‑infected rat cardiomyocytes | Q41672929 | ||
Desulfovibrio desulfuricans isolates from the gut of a single individual: structural and biological lipid A characterization | Q41723534 | ||
Contributions of microbes in vertebrate gastrointestinal tract to production and conservation of nutrients | Q41751222 | ||
Protective effect of endogenous hydrogen sulfide against oxidative stress in gastric ischemia-reperfusion injury | Q41828048 | ||
Hydrogen sulfide protects against myocardial ischemia and reperfusion injury by activating AMP-activated protein kinase to restore autophagic flux | Q41918586 | ||
The smooth muscle relaxant effect of hydrogen sulphide in vitro: evidence for a physiological role to control intestinal contractility | Q42059284 | ||
Hydrogen sulfide and resolution of acute inflammation: A comparative study utilizing a novel fluorescent probe. | Q42090940 | ||
Characterization of the enzymic capacity for cysteine desulphhydration in liver and kidney of the rat | Q42122753 | ||
Inhibition of endogenous hydrogen sulfide synthesis by PAG protects against ethanol-induced gastric damage in the rat. | Q43207390 | ||
Interactions between gut microbiota, host genetics and diet relevant to development of metabolic syndromes in mice | Q43253088 | ||
A fatality caused by accidental production of hydrogen sulfide | Q43812494 | ||
Production of volatile sulfur compounds by various Fusobacterium species | Q44014208 | ||
The gaseous mediator, hydrogen sulphide, inhibits in vitro motor patterns in the human, rat and mouse colon and jejunum | Q44016650 | ||
A novel pathway for the production of hydrogen sulfide from D-cysteine in mammalian cells | Q44131370 | ||
Biological activity of Desulfovibrio desulfuricans lipopolysaccharides evaluated via interleukin-8 secretion by Caco-2 cells | Q44330382 | ||
The effect of 5-aminosalicylic acid-containing drugs on sulfide production by sulfate-reducing and amino acid-fermenting bacteria | Q44375240 | ||
Sulfate-reducing anaerobic bacteria in human feces | Q44437721 | ||
Hydrogen sulfide prevents ethanol-induced gastric damage in mice: role of ATP-sensitive potassium channels and capsaicin-sensitive primary afferent neurons. | Q44572022 | ||
Hydrogen sulfide protects neurons from oxidative stress | Q44904699 | ||
Pharmacological investigation of hydrogen sulfide (H2S) contractile activity in rat detrusor muscle. | Q45284206 | ||
Association between fecal hydrogen sulfide production and pouchitis | Q45300584 | ||
Hydrogen sulfide and methyl mercaptan in periodontal pockets | Q45735264 | ||
Endogenous and exogenous hydrogen sulfide promotes resolution of colitis in rats | Q46046531 | ||
Hydrogen sulfide protects from intestinal ischaemia-reperfusion injury in rats | Q46141153 | ||
The inhibitory role of hydrogen sulfide in airway hyperresponsiveness and inflammation in a mouse model of asthma | Q46179201 | ||
Endogenous hydrogen sulfide regulates inflammatory response by activating the ERK pathway in polymicrobial sepsis | Q46392031 | ||
Hydrogen sulfide is a novel mediator of lipopolysaccharide-induced inflammation in the mouse | Q46465914 | ||
Occurrence of sulphate-reducing bacteria in human faeces and the relationship of dissimilatory sulphate reduction to methanogenesis in the large gut. | Q46593547 | ||
Hydrogen sulfide accelerates the recovery of kidney tubules after renal ischemia/reperfusion injury | Q46705377 | ||
The possible role of hydrogen sulfide as an endogenous smooth muscle relaxant in synergy with nitric oxide. | Q46738154 | ||
H2S: a universal defense against antibiotics in bacteria | Q46754342 | ||
Role of hydrogen sulfide in cecal ligation and puncture-induced sepsis in the mouse | Q46905143 | ||
Hydrogen sulphide-induced hypothermia attenuates stress-related ulceration in rats | Q46946123 | ||
The microbiota of the gut in preschool children with normal and excessive body weight. | Q47312781 | ||
Induction of anxiety-like behavior in mice during the initial stages of infection with the agent of murine colonic hyperplasia Citrobacter rodentium | Q48436487 | ||
The Purification and Subunit Structure of Cysteine Desulfhydrase from Salmonella typhimurium | Q50235924 | ||
Interaction of hydrogen sulfide with ion channels | Q37773403 | ||
Hydrogen sulfide in gastrointestinal and liver physiopathology | Q37833119 | ||
Emerging role of hydrogen sulfide in colonic physiology and pathophysiology | Q37889839 | ||
Physiological implications of hydrogen sulfide: a whiff exploration that blossomed | Q38005671 | ||
Hydrogen sulfide signaling in the gastrointestinal tract | Q38098623 | ||
H2 S modulates duodenal motility in male rats via activating TRPV1 and K(ATP) channels | Q38274850 | ||
Hydrogen sulfide-based therapeutics: exploiting a unique but ubiquitous gasotransmitter | Q38409371 | ||
Effects of inhibitors of hydrogen sulphide synthesis on rat colonic motility. | Q38649892 | ||
L-Cysteine/D,L-homocysteine-regulated ileum motility via system L and B°(,+) transporter: Modification by inhibitors of hydrogen sulfide synthesis and dietary treatments | Q38850455 | ||
ROS-Dependent Neuroprotective Effects of NaHS in Ischemia Brain Injury Involves the PARP/AIF Pathway | Q38854968 | ||
Hydrogen sulfide protected gastric epithelial cell from ischemia/reperfusion injury by Keap1 s-sulfhydration, MAPK dependent anti-apoptosis and NF-κB dependent anti-inflammation pathway | Q39032766 | ||
Hydrogen sulfide-releasing NSAIDs inhibit the growth of human cancer cells: a general property and evidence of a tissue type-independent effect | Q39416914 | ||
Production of the gaseous signal molecule hydrogen sulfide in mouse tissues | Q39566741 | ||
Tetrathionate reduction and production of hydrogen sulfide from thiosulfate | Q39659900 | ||
The role of Desulfovibrio desulfuricans lipopolysaccharides in modulation of periodontal inflammation through stimulation of human gingival fibroblasts. | Q39686263 | ||
Hydrogen sulfide attenuates ischemia-reperfusion injury in in vitro and in vivo models of intestine free tissue transfer. | Q39697644 | ||
Molecular mechanism for H(2)S-induced activation of K(ATP) channels | Q39796958 | ||
GYY4137, a novel hydrogen sulfide-releasing molecule, protects against endotoxic shock in the rat. | Q39859585 | ||
Markedly reduced toxicity of a hydrogen sulphide-releasing derivative of naproxen (ATB-346). | Q39884340 | ||
Effects of hydrogen sulphide on motility patterns in the rat colon. | Q39989635 | ||
Protective effects of vitamin B6 alone and in combination with L-cysteine and NaHS on ethanol and indomethacin-induced gastric lesions in mice | Q40101486 | ||
Hydrogen sulfide induces the synthesis of proinflammatory cytokines in human monocyte cell line U937 via the ERK-NF-kappaB pathway | Q40173017 | ||
Hydrogen sulfide is a novel prosecretory neuromodulator in the Guinea-pig and human colon. | Q40209080 | ||
Evidence that hydrogen sulfide is a genotoxic agent. | Q40323156 | ||
Enhanced Escherichia coli adherence and invasion in Crohn's disease and colon cancer | Q40538834 | ||
Occupational fatality and persistent neurological sequelae after mass exposure to hydrogen sulfide | Q40614152 | ||
Hydrogen sulfide improves cardiomyocytes electrical remodeling post ischemia/reperfusion injury in rats | Q35144947 | ||
Hydrogen sulfide modulates contractile function in rat jejunum | Q35204495 | ||
Hydrogen sulphide protects against NSAID-enteropathy through modulation of bile and the microbiota. | Q35314338 | ||
Fusobacterium nucleatum infection of colonic cells stimulates MUC2 mucin and tumor necrosis factor alpha | Q35328976 | ||
The contribution of sulphate reducing bacteria and 5-aminosalicylic acid to faecal sulphide in patients with ulcerative colitis | Q35358530 | ||
Role of the commensal microbiota in normal and pathogenic host immune responses | Q35448732 | ||
Oral administration of Bifidobacterim bifidum for modulating microflora, acid and bile resistance, and physiological indices in mice. | Q35550821 | ||
Hydrogen sulfide protects from colitis and restores intestinal microbiota biofilm and mucus production. | Q35571298 | ||
Hydrogen sulfide regulates the colonic motility by inhibiting both L-type calcium channels and BKCa channels in smooth muscle cells of rat colon | Q35587624 | ||
Abundance and diversity of mucosa-associated hydrogenotrophic microbes in the healthy human colon. | Q35634656 | ||
Role of Hydrogen Sulfide in Ischemia-Reperfusion Injury. | Q35647095 | ||
GYY4137 protects against myocardial ischemia and reperfusion injury by attenuating oxidative stress and apoptosis in rats | Q35666649 | ||
Desulfovibrio desulfuricans bacteremia in an immunocompromised host with a liver graft and ulcerative colitis | Q35668298 | ||
Role of hydrogen sulfide as a gasotransmitter in modulating contractile activity of circular muscle of rat jejunum | Q35693320 | ||
Oral Administration of P. gingivalis Induces Dysbiosis of Gut Microbiota and Impaired Barrier Function Leading to Dissemination of Enterobacteria to the Liver | Q35719237 | ||
Glycomacropeptide is a prebiotic that reduces Desulfovibrio bacteria, increases cecal short-chain fatty acids, and is anti-inflammatory in mice. | Q35739492 | ||
Hydrogen sulphide and mild hypothermia activate the CREB signaling pathway and prevent ischemia-reperfusion injury | Q35748474 | ||
Role of colonic microbiota in colorectal carcinogenesis: a systematic review. | Q35833931 | ||
Intestinal microbiota determine severity of myocardial infarction in rats | Q35863790 | ||
Hydrogen sulfide preconditioning or neutrophil depletion attenuates ischemia-reperfusion-induced mitochondrial dysfunction in rat small intestine | Q35939346 | ||
Enhanced activity of a hydrogen sulphide-releasing derivative of mesalamine (ATB-429) in a mouse model of colitis | Q36052635 | ||
Emerging roles for cyclooxygenase-2 in gastrointestinal mucosal defense | Q36075305 | ||
Dietary-fat-induced taurocholic acid promotes pathobiont expansion and colitis in Il10-/- mice | Q36087089 | ||
The phs gene and hydrogen sulfide production by Salmonella typhimurium | Q36236471 | ||
Small β2-glycoprotein I peptides protect from intestinal ischemia reperfusion injury | Q36374030 | ||
Microbial pathways in colonic sulfur metabolism and links with health and disease | Q36429327 | ||
Cystathionine γ-lyase protects against renal ischemia/reperfusion by modulating oxidative stress | Q36796570 | ||
Metabolic niche of a prominent sulfate-reducing human gut bacterium | Q37103860 | ||
The hydrogen sulfide donor, GYY4137, exhibits anti-atherosclerotic activity in high fat fed apolipoprotein E(-/-) mice | Q37122696 | ||
Hydrogen sulfide triggers late-phase preconditioning in postischemic small intestine by an NO- and p38 MAPK-dependent mechanism | Q37138975 | ||
The complex effects of the slow-releasing hydrogen sulfide donor GYY4137 in a model of acute joint inflammation and in human cartilage cells. | Q37295023 | ||
Enzymatic basis for assimilatory and dissimilatory sulfate reduction | Q37473526 | ||
Hydrogen sulfide [corrected] increases survival during sepsis: protective effect of CHOP inhibition | Q37624125 | ||
Potential role of the gaseous mediator hydrogen sulphide (H2S) in inhibition of human colonic contractility | Q50452581 | ||
Effects of sodium hydrosulfide on intestinal mucosal injury in a rat model of cardiac arrest and cardiopulmonary resuscitation. | Q50945343 | ||
Invasive potential of gut mucosa-derived Fusobacterium nucleatum positively correlates with IBD status of the host. | Q51174426 | ||
Production and elimination of sulfur-containing gases in the rat colon. | Q51570141 | ||
PI3K/SGK1/GSK3β signaling pathway is involved in inhibition of autophagy in neonatal rat cardiomyocytes exposed to hypoxia/reoxygenation by hydrogen sulfide. | Q51613789 | ||
Toxic effects of hydrogen sulfide: experience with three simultaneous patients. | Q51626355 | ||
Protective effect of hydrogen sulfide on TNF-α and IFN-γ-induced injury of intestinal epithelial barrier function in Caco-2 monolayers. | Q52926235 | ||
Proresolution effects of hydrogen sulfide during colitis are mediated through hypoxia-inducible factor-1α. | Q53655255 | ||
The use of the l-serine sulfhydrylase assay for the estimation of cystathionine β-synthase | Q53690944 | ||
Effects of a hydrogen sulfide donor on spontaneous contractile activity of rat stomach and jejunum. | Q54260180 | ||
Streptococcus anginosus l-cysteine desulfhydrase gene expression is associated with abscess formation in BALB/c mice. | Q54374511 | ||
Desulfovibrio desulfuricans lipopolysaccharides induce endothelial cell IL-6 and IL-8 secretion and E-selectin and VCAM-1 expression. | Q54738030 | ||
Fecal Hydrogen Sulfide Production in Ulcerative Colitis | Q56094845 | ||
Hydrogen sulfide-mediated regulation of contractility in the mouse ileum with electrical stimulation: roles of L-cysteine, cystathionine β-synthase, and K+ channels | Q57109065 | ||
Sulfate-reducing bacteria in human feces and their association with inflammatory bowel diseases | Q61607084 | ||
A survey of methionine adenosyltransferase and cystathionine gamma-lyase activities in ruminant tissues | Q68869156 | ||
Studies on the oxygen radical mechanism involved in the small intestinal reperfusion damage | Q70103443 | ||
Reducing sulfur compounds of the colon impair colonocyte nutrition: implications for ulcerative colitis | Q70578284 | ||
Thiol S-methyltransferase: suggested role in detoxication of intestinal hydrogen sulfide | Q71391175 | ||
Ischemic injury in the cat small intestine: Role of superoxide radicals | Q72915002 | ||
Sulfate-reducing bacteria in association with human periodontitis | Q73350914 | ||
Oxidation of hydrogen sulfide and methanethiol to thiosulfate by rat tissues: a specialized function of the colonic mucosa | Q73965302 | ||
In vivo butyrate metabolism and colonic permeability in extensive ulcerative colitis | Q77164877 | ||
Sulfide enhancement of PMN apoptosis | Q77296343 | ||
Sulfur reduction by human erythrocytes | Q77356166 | ||
Hydrogen sulfide acts as an inflammatory mediator in cecal ligation and puncture-induced sepsis in mice by upregulating the production of cytokines and chemokines via NF-kappaB | Q79512390 | ||
Hydrogen sulfide enhances ulcer healing in rats | Q80624339 | ||
Acute hydrogen sulfide toxicity due to sewer gas exposure | Q81079405 | ||
Endogenous hydrogen sulfide is an anti-inflammatory molecule in dextran sodium sulfate-induced colitis in mice | Q82086671 | ||
Gastroprotective effect of NaHS against mucosal lesions induced by ischemia-reperfusion injury in rat | Q83311269 | ||
Functional dysbiosis within the gut microbiota of patients with constipated-irritable bowel syndrome | Q83403902 | ||
Eukaryotic and prokaryotic contributions to colonic hydrogen sulfide synthesis | Q83808894 | ||
Volatile sulfur compounds produced by Helicobacter pylori | Q83834012 | ||
Hydrogen sulfide decreases the levels of ROS by inhibiting mitochondrial complex IV and increasing SOD activities in cardiomyocytes under ischemia/reperfusion | Q83891093 | ||
Hydrogen sulphide synthesis in the rat and mouse gastrointestinal tract | Q84153958 | ||
Hydrogen sulfide augments survival signals in warm ischemia and reperfusion of the mouse liver | Q85895942 | ||
P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
P6216 | copyright status | copyrighted | Q50423863 |
P433 | issue | 4 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | physiology | Q521 |
P304 | page(s) | 866-89 | |
P577 | publication date | 2015-11-12 | |
P1433 | published in | Microorganisms | Q27725360 |
P1476 | title | Hydrogen Sulfide in Physiology and Diseases of the Digestive Tract | |
P478 | volume | 3 |
Q42356337 | A Synthetic Supramolecular Receptor for the Hydrosulfide Anion. |
Q64272596 | A glycyl radical enzyme enables hydrogen sulfide production by the human intestinal bacterium |
Q47762321 | A timeline of hydrogen sulfide (H2S) research: From environmental toxin to biological mediator |
Q59807022 | Anaerobic Degradation of the Plant Sugar Sulfoquinovose Concomitant With HS Production: K-12 and sp. Strain DF1 as Co-culture Model |
Q88801159 | Association of hyperhomocysteinemia with genetic variants in key enzymes of homocysteine metabolism and methotrexate toxicity in rheumatoid arthritis patients |
Q92602995 | Cerumenogram: a new frontier in cancer diagnosis in humans |
Q47430972 | Chemical Biology of H2S Signaling through Persulfidation |
Q31157045 | Data Mining Techniques Applied to Hydrogen Lactose Breath Test |
Q92665783 | Deficiency of Gankyrin in the small intestine is associated with augmented colitis accompanied by altered bacterial composition of intestinal microbiota |
Q96170645 | Dendrobium officinale Kimura et Migo and American ginseng mixture: A Chinese herbal formulation for gut microbiota modulation |
Q39241653 | Determinants of hypoxia inducible factor (HIF) activity in the intestinal mucosa |
Q52326681 | Dietary and Endocrine Regulation of Endogenous Hydrogen Sulfide Production: Implications for Longevity. |
Q58133618 | Does Modification of the Large Intestinal Microbiome Contribute to the Anti-Inflammatory Activity of Fermentable Fiber? |
Q91878791 | Effects of treatment with enrofloxacin or tulathromycin on fecal microbiota composition and genetic function of dairy calves |
Q39042753 | Enterosalivary nitrate metabolism and the microbiome: Intersection of microbial metabolism, nitric oxide and diet in cardiac and pulmonary vascular health |
Q92106368 | Gut Microbiome and Modulation of CNS Function |
Q90043564 | Gut Microbiota and Cancer of the Host: Colliding Interests |
Q89736866 | Hydrogen Sulfide Protects against Paraquat-Induced Acute Liver Injury in Rats by Regulating Oxidative Stress, Mitochondrial Function, and Inflammation |
Q50075649 | Hydrogen Sulfide Releasing 2-Mercaptoacrylic Acid-Based Derivative Possesses Cytoprotective Activity in a Small Intestine of Rats with Medication-Induced Enteropathy |
Q36181782 | Impact of cystic fibrosis disease on archaea and bacteria composition of gut microbiota. |
Q42365523 | Initial stage of the biofilm formation on the NiTi and Ti6Al4V surface by the sulphur-oxidizing bacteria and sulphate-reducing bacteria. |
Q101403114 | Mucosal microbiota and gene expression are associated with long-term remission after discontinuation of adalimumab in ulcerative colitis |
Q92677852 | Nitric Oxide and Hydrogen Sulfide Regulation of Ischemic Vascular Growth and Remodeling |
Q46237980 | Possible role of the gut microbiota-brain axis in the antidepressant effects of (R)-ketamine in a social defeat stress model. |
Q49483670 | Pretreatment with probiotic Bifico ameliorates colitis-associated cancer in mice: Transcriptome and gut flora profiling. |
Q90043563 | Recycling the Interspecific Relations with Epithelial Cells: Bacteria and Cancer Metabolic Symbiosis |
Q61818564 | Role of Oral Microbiota in Cancer Development |
Q46327421 | Sulfur Cycling and the Intestinal Microbiome |
Q90397401 | Synergisms, Discrepancies and Interactions between Hydrogen Sulfide and Carbon Monoxide in the Gastrointestinal and Digestive System Physiology, Pathophysiology and Pharmacology |
Q91966173 | Temperature Effects on Methanogenesis and Sulfidogenesis during Anaerobic Digestion of Sulfur-Rich Macroalgal Biomass in Sequencing Batch Reactors |
Q97518452 | The Effects of Nutrition on the Gastrointestinal Microbiome of Cats and Dogs: Impact on Health and Disease |
Q90731554 | The evolving landscape for cellular nitric oxide and hydrogen sulfide delivery systems: A new era of customized medications |
Q88380263 | Updates in the Metabolic Management of Calcium Stones |
Search more.